Nomura Holdings
BPMC

Nomura Holdings’s Blueprint Medicines BPMC Stock Holding History

Nomura Holdings’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,506
Closed -$270K – 1569
2024
Q2 		$270K Sell
2,506
-4,958
-66% -$496K ﹤0.01% 1497
2024
Q1 		$708K Buy
7,464
+2,964
+66% +$254K ﹤0.01% 1192
2023
Q4 		$415K Sell
4,500
-6,000
-57% -$389K ﹤0.01% 1400
2023
Q3 		$527K Buy
+10,500
New +$561K ﹤0.01% 1118
2023
Q2 		– Sell
-106,693
Closed -$4.8M – 1382
2023
Q1 		$4.8M Sell
106,693
-22,758
-18% -$1.03M 0.02% 568
2022
Q4 		$5.67M Buy
129,451
+121,440
+1,516% +$5.82M 0.02% 459
2022
Q3 		$528K Sell
8,011
-95,240
-92% -$6.12M ﹤0.01% 1096
2022
Q2 		$5.15M Buy
+103,251
New +$6.05M 0.02% 539
2020
Q3 		– Sell
-3,696
Closed -$288K – 1316
2020
Q2 		$288K Sell
3,696
-5,804
-61% -$393K ﹤0.01% 956
2020
Q1 		$554K Sell
9,500
-6,889
-42% -$443K ﹤0.01% 652
2019
Q4 		$1.31M Buy
+16,389
New +$1.23M ﹤0.01% 737
2019
Q3 		– Sell
-12,500
Closed -$1.21M – 1184
2019
Q2 		$1.21M Buy
+12,500
New +$1.03M 0.01% 782

Other funds holding BPMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nomura Holdings's BPMC Position: Q3 2024 in Review

Nomura Holdings sold out of Blueprint Medicines (BPMC) in Q3 2024, closing a stake of 2,506 shares — an estimated $270K sold.

Nomura Holdings first reported a position in BPMC in Q2 2019 and held it in 12 quarters. The position peaked at $5.67M in Q4 2022. 319 funds tracked by Wall St. Rank hold BPMC as of Q3 2024.

  • Nomura Holdings reported no remaining Blueprint Medicines position as of Q3 2024 after selling out during the quarter.
  • Nomura Holdings sold 2,506 Blueprint Medicines shares in Q3 2024, an estimated $270K.
  • Nomura Holdings first reported a position in Blueprint Medicines in Q2 2019 and held it in 12 quarters.
  • Nomura Holdings's Blueprint Medicines position peaked at $5.67M in Q4 2022.
  • 319 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2024.

Based on Nomura Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.